Cell Research for BNCT
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 652
Special Issue Editors
2. Neutron Therapy Research Center, Okayama University, Okayama 700-8530, Japan
3. German Society for Boron Neutron Capture Therapy, 45122 Essen, Germany
Interests: radiation oncology; hadron therapy; boron neutron capture therapy (BNCT); neutrons; high-LET radiation; radiation biology; eye tumors; ophthalmic oncology
Special Issues, Collections and Topics in MDPI journals
Interests: Boron Neutron Capture therapy (BNCT); accelerators; neutrons
2. Budker Institute of Nuclear Physics, 630090 Novosibirsk, Russia
3. Novosibirsk State University, 630090 Novosibirsk, Russia
Interests: oncology; cell biology; Boron Neutron Capture therapy (BNCT); skin cancer; melanoma; angiogenesis; lymphangiogenesis
Special Issue Information
Dear Colleagues,
From July 11 to 13, 2022, the 11th YBNCT Meeting will be organized as a hybrid event by our colleagues at the Budker Institute in Novosibirsk. The journal Cells has decided to publish a Special Issue for the occasion, with the stated goal of giving young scientists the opportunity to publish their research results in a high-ranking peer-reviewed journal. The publisher MDPI has further proposed that this Special Issue be included in the Special Issue Mentor Program. This program provides an opportunity for early career scientists (new faculty, postdoc graduate students, etc.) to enhance their editing, networking, and organizational skills, and to work closely with the journal to gain more editorial experience. Aleksandr Makarov and Iuliia Taskaeva will edit this Special Issue as guest editors with Prof. Sauerwein as a mentor.
The Special Issue is entitled "Cell Research for BNCT".
We invite your contributions, in the form of original research articles, reviews, or shorter perspective articles, on all cellular aspects related to the theme of BNCT.
Relevant topics include, but are not limited to, the following:
- Radiation biology for BNCT;
- Cell-based studies;
- Preclinical animal studies;
- Drug development for BNCT;
- Impact of BNCT on the proteomic profile and omics approaches;
- Boron imaging;
- Mechanisms of action of BNCT;
- Abscopal effect of BNCT;
- Early clinical trials;
- Biomarkers for therapeutic optimization.
Prof. Dr. Wolfgang Sauerwein
Dr. Aleksandr Makarov
Dr. Iuliia Taskaeva
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- BNCT
- Boron Neutron Capture therapy
- biomarkers for therapeutic optimization
